[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353661-105":59,"doc-detail-353661-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dissecting-the-role-of-epigenetic-regulation-in-oral-squamous-cell-carcinoma-microenvironment-mechanisms-and-therapeutics","Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment - mechanisms and therapeutics","","Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with persistently high mortality driven by therapy resistance and tumor recurrence. This review analyzes the epigenetic dysregulation–tumor microenvironment (TME) interplay that shapes OSCC progression. It highlights how DNA methylation, histone modifications, and non-coding RNAs reprogram cancer cells and coordinate a protumorigenic TME, contributing to resistance against standard therapies. It also evaluates epigenetic drug strategies and engineered extracellular vesicles, and supports rational combinations to improve clinical outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dissecting-the-role-of-epigenetic-regulation-in-oral-squamous-cell-carcinoma-microenvironment-mechanisms-and-therapeutics/353661/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dissecting-the-role-of-epigenetic-regulation-in-oral-squamous-cell-carcinoma-microenvironment-mechanisms-and-therapeutics/353661.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the central focus of this review on OSCC?","Question",{"text":112,"@type":113},"The review focuses on how epigenetic regulation interacts with the tumor microenvironment to drive oral squamous cell carcinoma progression and therapy resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which epigenetic mechanisms are emphasized?",{"text":117,"@type":113},"It emphasizes DNA methylation, histone modifications, and regulation by non-coding RNAs as major contributors to OSCC pathogenesis.",{"name":119,"@type":110,"acceptedAnswer":120},"How can epigenetic therapies potentially improve OSCC treatment?",{"text":121,"@type":113},"The review discusses targeting epigenetic pathways using epigenetic drugs such as DNMT inhibitors and HDAC inhibitors, as well as engineered extracellular vesicles, and proposes rational combinations with conventional treatments or immunotherapy to overcome drug resistance.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353661,1790814766,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","TYPE Review  \nPUBLISHED 26 January 2026  \nDOI 10.3389/fimmu.2026.1758433  \nOPEN ACCESS  \nEDITED BY  \nMin-Ke He,  \nSun Yat-sen University Cancer Center (SYSUCC), China  \nREVIEWED BY  \nCanhua Huang, Sichuan University, China João Silva,  \nCooperativa de Ensino Superior Polite´cnico e Universit´ario, Portugal  \n*CORRESPONDENCE  \nZhenglin He  \n [lioushe@126.com](lioushe@126.com)[ ](lioushe@126.com)Guanyu Chen  \n [guanyu.chen@uni-marburg.de](guanyu.chen@uni-marburg.de)  \n†These authors have contributed equally to this work  \nRECEIVED 01 December 2025  \nREVISED 24 December 2025  \nACCEPTED 02 January 2026  \nPUBLISHED 26 January 2026  \nCITATION  \nLi X, Ren Y, Pei S, Zhao K, Chen G and He Z (2026) Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment:  \nmechanisms and therapeutics.  \nFront. Immunol. 17:1758433 .  \ndoi: 10.3389/fimmu.2026.1758433  \nCOPYRIGHT  \n© 2026 Li, Ren, Pei, Zhao, Chen and He. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nDissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment: mechanisms and therapeutics  \nXuechao Li 1†, Yifei Ren 1†, Shenghua Pei 1, Kai Zhao 2,3, Guanyu Chen 4* and Zhenglin He 5*  \n1School and Hospital of Stomatology, Jilin University, Changchun, China, 2 Department of Immunobiology, Yale University School of Medicine, New Haven, CT, United States, 3Center of Molecular and Cellular Oncology, Yale Cancer Center, Yale University, New Haven, CT, United States, 4 Department of Experimental Orofacial Medicine, Marburg University, Marburg, Germany, 5ChinaJapan Union Hospital of Jilin University, Jilin University, Changchun, China  \nOral squamous cell carcinoma (OSCC) is a prevalent and aggressive malignancy with a persistently high mortality rate, largely attributable to therapy resistance and tumor recurrence. This review comprehensively explores the critical interplay between epigenetic dysregulation and the tumor microenvironment (TME) in driving OSCC progression. We detail how key epigenetic mechanisms, including DNA methylation, histone modiﬁcations, and non-coding RNAs (ncRNAs), intrinsically transform cancer cells and actively orchestrate protumorigenic TME. These alterations substantially contribute to resistance against conventional therapies. Furthermore, we discuss the therapeutic potential of targeting these pathways using epigenetic drugs (epi-drugs), such as DNA methyltransferase (DNMT) inhibitors and histone deacetylase (HDAC) inhibitors, as well as engineered extracellular vesicles (EVs) . The primary objective of this review is to synthesize current knowledge on the epigenetic-TME axis, thereby providing a mechanistic foundation for developing novel therapeutic strategies. We emphasize that rational combinations of epigenetic-targeting agents with conventional treatments or immunotherapy hold signiﬁcant promise for overcoming drug resistance and improving clinical outcomes in OSCC patients.  \nKEYWORDS  \nbiomarkers, epigenetic regulation, oral squamous cell carcinoma, therapeutic targets, tumor microenvironment, DNA methylation, histone modiﬁcation, drug resistance  \nIntroduction  \nOral squamous cell carcinoma (OSCC) represents a signiﬁcant global health burden, accounting for over 90% of all oral malignancies. It is among the most common cancers worldwide, with incidence rates varying geographically and inﬂuenced by regional risk factors (1, 2) . Major risk factors include tobacco use, heavy alcohol consumption, betel quid  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \nchewing, and infection ","cbCaig5Bd2YFc54Y","https://ap.wps.com/l/cbCaig5Bd2YFc54Y","pdf",9426725,36,"English","# Introduction\n## Risk factors and clinical presentation\n## Current treatment strategies and resistance\n## Role of the tumor microenvironment\n# Epigenetic mechanisms in OSCC\n## DNA methylation\n## Histone modifications\n## Non-coding RNAs (ncRNAs)","[{\"question\":\"What is the central focus of this review on OSCC?\",\"answer\":\"The review focuses on how epigenetic regulation interacts with the tumor microenvironment to drive oral squamous cell carcinoma progression and therapy resistance.\"},{\"question\":\"Which epigenetic mechanisms are emphasized?\",\"answer\":\"It emphasizes DNA methylation, histone modifications, and regulation by non-coding RNAs as major contributors to OSCC pathogenesis.\"},{\"question\":\"How can epigenetic therapies potentially improve OSCC treatment?\",\"answer\":\"The review discusses targeting epigenetic pathways using epigenetic drugs such as DNMT inhibitors and HDAC inhibitors, as well as engineered extracellular vesicles, and proposes rational combinations with conventional treatments or immunotherapy to overcome drug resistance.\"}]","Dissecting the role of epigenetic regulation in oral squamous cell carcinoma microenvironment - mechanisms and therapeutics | PDF",1790106603,91,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7c6d42cf325d82f9173d32c2ae35b569.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64798c6e94cbec6c0e8621a3540bdd65.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5be173ecd80f5ffff646c10f4c5cf72c.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53bdd8ef36757c99dbebb90390014a63.webp",980,1385]